Rayonier Advanced Materials (RYAM) Fireside Chat summary
Event summary combining transcript, slides, and related documents.
Fireside Chat summary
3 Feb, 2026Introduction and agenda
The session featured Joshua Hicks, Senior Vice President of the High Purity Cellulose (HPC) business, discussing the transformation and strategy of the business unit.
Background and experience of the speaker
Joshua Hicks joined the company 2.5 years ago, bringing extensive experience in specialty chemicals and ingredients.
He was motivated by the opportunity to shift the company from a commodity pulp manufacturer to a specialty materials company and to drive shareholder value.
Current industry trends
The HPC business is divided into cellulose specialties (CS), fluff, and non-fluff commodities, with CS being the market leader and generating healthy EBITDA margins in the mid-20s%.
The fluff business targets high-value, growth areas like adult incontinence, aligning with demographic trends.
The non-fluff commodities segment has negative EBITDA margins, prompting an indefinite suspension of the Temiscaming, Canada line to reduce exposure.
By year-end, exposure to commodity segments is expected to be halved.
The market is highly concentrated, with the top three CS producers holding 80% of the market.
Recent capacity rationalizations, including the closure of the Georgia-Pacific Foley plant and the suspension of Temiscaming, are tightening supply-demand balance.
Latest events from Rayonier Advanced Materials
- Board refresh, CEO change, and governance reforms highlight a focus on accountability and performance.RYAM
Proxy filing20 Mar 2026 - 2026 targets positive cash flow, EBITDA growth, and new product launches amid disciplined execution.RYAM
Gabelli Funds Annual Specialty Chemicals Symposium20 Mar 2026 - 2025 results showed lower revenue and EBITDA, with 2026 targeting free cash flow recovery.RYAM
Q4 20254 Mar 2026 - Aiming to double EBITDA by 2027, leveraging price, cost, and biomaterials growth.RYAM
17th Annual Southwest IDEAS Conference3 Feb 2026 - Shifting to specialty cellulose and biomaterials, with debt reduction and margin expansion in focus.RYAM
Small-Cap Growth Virtual Investor Conference3 Feb 2026 - Q2 net sales and earnings surged, with 2024 guidance raised and cash flow outlook improved.RYAM
Q2 20242 Feb 2026 - Shifting to specialty cellulose and biomaterials, with asset sales and debt reduction underway.RYAM
Stifel 2024 Cross Sector Insight Conference1 Feb 2026 - Q3 net sales and Adjusted EBITDA surged, 2024 guidance held, and $700M refinancing secured.RYAM
Q3 202416 Jan 2026 - Focus on specialty cellulose, biomaterials, and debt reduction drives margin and cash flow growth.RYAM
Gabelli Funds' 16th Annual Specialty Chemicals Symposium26 Dec 2025